Granules and NIPER Collaborate to Establish Cutting-Edge Centre of Excellence

Granules India and the National Institute of Pharmaceutical Education and Research (NIPER), located in Mohali, Chandigarh, have solidified their commitment to advancing pharmaceutical innovation through a Memorandum of Understanding (MoU) that paves the way for the establishment of the Chigurupati Centre of Excellence in Innovative and Sustainable Pharmaceutical Development (CCE-ISPD).

Krishna Prasad Chigurupati, the Chairman and Managing Director of Granules India, expressed their dedication to pushing the boundaries of pharmaceutical innovation. He emphasized that the collaboration with NIPER is not only focused on life-saving medicines but also on making a meaningful difference.

"The CCE-ISPD stands as a testament to our unwavering commitment to sustainable pharmaceutical development. We are eagerly looking forward to the transformative impact it will bring to both the industry and society," Chigurupati stated.

Dulal Panda, the Director of NIPER, shared his perspective on the partnership, noting that the CCE-ISPD will serve as a nurturing ground for fostering innovative ideas and sustainable solutions, ultimately shaping the future of the pharmaceutical industry.

"We are honored to collaborate with Granules India, and together, we are poised to redefine the landscape of sustainable pharmaceutical research and development," Panda added.

This partnership between Granules India and NIPER signifies a significant step toward the advancement of pharmaceutical innovation and sustainability, with the CCE-ISPD poised to play a pivotal role in shaping the future of pharmaceutical research and development.

HBL